CYTOKINETICS, INCORPORATED AND , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF [●], 20Preferred Stock Warrant Agreement • November 3rd, 2017 • Cytokinetics Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 3rd, 2017 Company Industry JurisdictionTHIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [●], between CYTOKINETICS, INCORPORATED, a Delaware corporation (the “Company”) and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
CYTOKINETICS, INCORPORATED AND , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF [●], 20Common Stock Warrant Agreement • November 3rd, 2017 • Cytokinetics Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 3rd, 2017 Company Industry JurisdictionTHIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [●], between CYTOKINETICS, INCORPORATED, a Delaware corporation (the “Company”) and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
CYTOKINETICS, INCORPORATED and , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [●], 20Warrant Agreement • November 3rd, 2017 • Cytokinetics Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 3rd, 2017 Company Industry JurisdictionThis DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between CYTOKINETICS, INCORPORATED, a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).